Michael G. Leahy PhD , Denis J. Wakeham PhD , James P. MacNamara MD , Tiffany Brazile MD , Abidan Abulimiti MD, PhD , Christopher M. Hearon Jr. PhD , Mitchel Samels MSc , Andrew R. Tomlinson MD , Bryce N. Balmain PhD , Tony G. Babb PhD , Benjamin D. Levine MD , Satyam Sarma MD
{"title":"Heart-Lung Interactions in HFpEF","authors":"Michael G. Leahy PhD , Denis J. Wakeham PhD , James P. MacNamara MD , Tiffany Brazile MD , Abidan Abulimiti MD, PhD , Christopher M. Hearon Jr. PhD , Mitchel Samels MSc , Andrew R. Tomlinson MD , Bryce N. Balmain PhD , Tony G. Babb PhD , Benjamin D. Levine MD , Satyam Sarma MD","doi":"10.1016/j.jchf.2025.102523","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Patients with heart failure with preserved ejection fraction (HFpEF) are characterized by an exaggerated rise in pulmonary capillary wedge pressure (PCWP) with exercise compared with healthy similar-aged adults. Due to the multisystemic effects of the disease, patients with HFpEF often experience expiratory flow limitation (EFL), thereby perpetuating dynamic hyperinflation (DH) and ventilation at a higher percentage of total lung volume. How lung mechanics and operational lung volume affect central hemodynamics in patients with HFpEF is not fully understood.</div></div><div><h3>Objectives</h3><div>The authors sought to characterize the association and correlation of DH and EFL on PCWP in adults with HFpEF during exercise.</div></div><div><h3>Methods</h3><div>A total of 55 patients with HFpEF (71 ± 7 years of age, 70% female) were studied at rest and during 20-W and peak exercise on an upright semirecumbent cycle ergometer. Right atrial and mean pulmonary artery (mPAP) pressures as well as PCWP (via right heart catheterization), oxygen uptake (indirect calorimetry), cardiac output (direct Fick), and ventilation (flow-volume parameters) were measured at each timepoint. DH was defined as an increase in end-expiratory lung volume of ≥150 mL from rest as determined by repeated inspiratory capacity maneuvers.</div></div><div><h3>Results</h3><div>PCWP was greater in those with DH at 20-W exercise (DH 24 ± 6 mm Hg vs typical 18 ± 6; <em>P =</em> 0.033) and peak exercise (DH 44 ± 9 vs typical 31 ± 6 mm Hg; <em>P =</em> 0.002). The degree of dynamic inflation was modestly, but significantly associated with a greater PCWP at 20-W (<em>r</em><sup>2</sup> = 0.196; <em>P =</em> 0.001) and peak (<em>r</em><sup>2</sup> = 0.204; <em>P <</em> 0.001) exercise, as was mPAP (both <em>P <</em> 0.001).</div></div><div><h3>Conclusions</h3><div>Patients with HFpEF that dynamically hyperinflate during exercise have greater PCWP as measured with reference to atmospheric pressure. The severity of hyperinflation scaled proportionally to higher exercise PCWP. Our findings suggest that the augmented exercise PCWP in patients with HFpEF may not be entirely attributed to ventricular stiffness, but also a consequence of increased intrathoracic pressure from dysfunctional ventilatory mechanics. (Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction; <span><span>NCT04068844</span><svg><path></path></svg></span>)</div></div>","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 8","pages":"Article 102523"},"PeriodicalIF":10.3000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Heart failure","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213177925004500","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Patients with heart failure with preserved ejection fraction (HFpEF) are characterized by an exaggerated rise in pulmonary capillary wedge pressure (PCWP) with exercise compared with healthy similar-aged adults. Due to the multisystemic effects of the disease, patients with HFpEF often experience expiratory flow limitation (EFL), thereby perpetuating dynamic hyperinflation (DH) and ventilation at a higher percentage of total lung volume. How lung mechanics and operational lung volume affect central hemodynamics in patients with HFpEF is not fully understood.
Objectives
The authors sought to characterize the association and correlation of DH and EFL on PCWP in adults with HFpEF during exercise.
Methods
A total of 55 patients with HFpEF (71 ± 7 years of age, 70% female) were studied at rest and during 20-W and peak exercise on an upright semirecumbent cycle ergometer. Right atrial and mean pulmonary artery (mPAP) pressures as well as PCWP (via right heart catheterization), oxygen uptake (indirect calorimetry), cardiac output (direct Fick), and ventilation (flow-volume parameters) were measured at each timepoint. DH was defined as an increase in end-expiratory lung volume of ≥150 mL from rest as determined by repeated inspiratory capacity maneuvers.
Results
PCWP was greater in those with DH at 20-W exercise (DH 24 ± 6 mm Hg vs typical 18 ± 6; P = 0.033) and peak exercise (DH 44 ± 9 vs typical 31 ± 6 mm Hg; P = 0.002). The degree of dynamic inflation was modestly, but significantly associated with a greater PCWP at 20-W (r2 = 0.196; P = 0.001) and peak (r2 = 0.204; P < 0.001) exercise, as was mPAP (both P < 0.001).
Conclusions
Patients with HFpEF that dynamically hyperinflate during exercise have greater PCWP as measured with reference to atmospheric pressure. The severity of hyperinflation scaled proportionally to higher exercise PCWP. Our findings suggest that the augmented exercise PCWP in patients with HFpEF may not be entirely attributed to ventricular stiffness, but also a consequence of increased intrathoracic pressure from dysfunctional ventilatory mechanics. (Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction; NCT04068844)
期刊介绍:
JACC: Heart Failure publishes crucial findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal is to enhance understanding through timely scientific communication on disease, clinical trials, outcomes, and therapeutic advances. The Journal fosters interdisciplinary connections with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery related to heart failure. It also covers articles on pharmacogenetics, biomarkers, and metabolomics.